Detalhe da pesquisa
1.
Socioeconomic inequality in prostate cancer diagnostics, primary treatment, rehabilitation, and mortality in Sweden.
Int J Cancer
; 2024 Mar 25.
Artigo
Inglês
| MEDLINE | ID: mdl-38526118
2.
Ki67 and prostate specific antigen are prognostic in metastatic hormone naïve prostate cancer.
Acta Oncol
; 62(12): 1698-1706, 2023 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-37713321
3.
Risk of severe late toxicity after radiotherapy following radical prostatectomy - a nationwide study.
BJU Int
; 130(6): 799-808, 2022 12.
Artigo
Inglês
| MEDLINE | ID: mdl-35523728
4.
Expression Levels of hgcAB Genes and Mercury Availability Jointly Explain Methylmercury Formation in Stratified Brackish Waters.
Environ Sci Technol
; 56(18): 13119-13130, 2022 09 20.
Artigo
Inglês
| MEDLINE | ID: mdl-36069707
5.
Hysterectomy after uterus transplantation and detailed analyses of graft failures.
Acta Obstet Gynecol Scand
; 101(3): 355-363, 2022 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-34907538
6.
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC): patient-reported quality-of-life outcomes of a randomised, controlled, non-inferiority, phase 3 trial.
Lancet Oncol
; 22(2): 235-245, 2021 02.
Artigo
Inglês
| MEDLINE | ID: mdl-33444529
7.
Deep learning-based classification and structure name standardization for organ at risk and target delineations in prostate cancer radiotherapy.
J Appl Clin Med Phys
; 22(12): 51-63, 2021 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-34623738
8.
Marked response to cabazitaxel in prostate cancer xenografts expressing androgen receptor variant 7 and reversion of acquired resistance by anti-androgens.
Prostate
; 80(2): 214-224, 2020 02.
Artigo
Inglês
| MEDLINE | ID: mdl-31799745
9.
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial.
Lancet
; 394(10196): 385-395, 2019 08 03.
Artigo
Inglês
| MEDLINE | ID: mdl-31227373
10.
Re-treatment with radium-223: 2-year follow-up from an international, open-label, phase 1/2 study in patients with castration-resistant prostate cancer and bone metastases.
Prostate
; 79(14): 1683-1691, 2019 10.
Artigo
Inglês
| MEDLINE | ID: mdl-31442327
11.
Platelets harbor prostate cancer biomarkers and the ability to predict therapeutic response to abiraterone in castration resistant patients.
Prostate
; 78(1): 48-53, 2018 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-29094381
12.
U-CAN: a prospective longitudinal collection of biomaterials and clinical information from adult cancer patients in Sweden.
Acta Oncol
; 57(2): 187-194, 2018 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-28631533
13.
Time on treatment with abiraterone in men with de novo metastatic castration sensitive prostate cancer: a drug utilization study.
Acta Oncol
; 61(3): 328-332, 2022 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-34979865
14.
Proinflammatory signaling regulates voluntary alcohol intake and stress-induced consumption after exposure to social defeat stress in mice.
Addict Biol
; 22(5): 1279-1288, 2017 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-27273552
15.
Melanin-Concentrating Hormone and Its MCH-1 Receptor: Relationship Between Effects on Alcohol and Caloric Intake.
Alcohol Clin Exp Res
; 40(10): 2199-2207, 2016 10.
Artigo
Inglês
| MEDLINE | ID: mdl-27579857
16.
Parental exposure to natural mixtures of persistent organic pollutants (POP) induced changes in transcription of apoptosis-related genes in offspring zebrafish embryos.
J Toxicol Environ Health A
; 79(13-15): 602-11, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-27484141
17.
Loss of metabotropic glutamate receptor 2 escalates alcohol consumption.
Proc Natl Acad Sci U S A
; 110(42): 16963-8, 2013 Oct 15.
Artigo
Inglês
| MEDLINE | ID: mdl-24082084
18.
The effects of PPAR-γ inhibition on gene expression and the progression of induced osteogenic differentiation of human mesenchymal stem cells.
Connect Tissue Res
; 55(4): 262-74, 2014 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-24708348
19.
Aflibercept versus placebo in combination with docetaxel and prednisone for treatment of men with metastatic castration-resistant prostate cancer (VENICE): a phase 3, double-blind randomised trial.
Lancet Oncol
; 14(8): 760-8, 2013 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-23742877
20.
[Drastic changes in the treatment of metastatic prostate cancer]. / Behandling av metastaserad prostatacancer.
Lakartidningen
; 1212024 Apr 23.
Artigo
Sueco
| MEDLINE | ID: mdl-38651316